Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging Study of Degarelix in Korean Patients with Prostate Cancer
NCT01071915Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2010
- Primary completion
- Nov 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Mar 2010; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01071915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071915.